Trial Outcomes & Findings for Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET (NCT NCT02152670)

NCT ID: NCT02152670

Last Updated: 2023-02-16

Results Overview

BPND is a measure of dopamine receptor availability

• Recruitment status: TERMINATED
• Study phase: NA
• Target enrollment: 1 participants
• Primary outcome timeframe: 2 weeks
• Results posted on: 2023-02-16

Participant Flow

Participant milestones

Measure	Enrolled and Randomized This summarizes the single patient enrolled and randomized to the study.
Overall Study STARTED	1
Overall Study COMPLETED	1
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: 2 weeks

Population: Only a single patient was enrolled and randomized.

BPND is a measure of dopamine receptor availability

Outcome measures

Outcome data not reported

Adverse Events

Enrolled and Randomized

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry

Yale University

Phone: (203) 974-7536

Email: gustavo.angarita@yale.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place